FDA Gives Expanded Approval to Prescription Fish Oil for Heart Patients
The U.S. Food and Drug Administration on Friday gave expanded approval to a prescription form of fish oil called Vascepa, to help prevent heart trouble in people at high risk who are already taking statins.
Vascepa (icosapent ethyl) was already FDA-approved for a small percentage of patients with exceptionally high blood levels of triglycerides, a type of blood fat.
The new approval greatly expands the potential pool of patients, because it now includes people with simply high levels of triglycerides — at or above 150 milligrams per deciliter — and multiple risk factors for heart disease and diabetes.
Retiree News 
Comments are closed.